Market Cap 895.00M
Revenue (ttm) 1.45B
Net Income (ttm) -92.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6.41%
Debt to Equity Ratio 0.00
Volume 81,000
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 43.03M
Stochastic %K 55%
Beta N/A
Analysts Strong Sell
Price Target $9.50
JFais
JFais Aug. 17 at 8:35 PM
$ATTO (NP) Too early-stage for me, but wanted to highlight yet another of the latest biotech IPO's to be performing well out of the gate $XBI As long as this is the trend for newly public co's, bodes well for the sector (vs all the science projects & bio-blowups we saw prior)
0 · Reply
Invescent
Invescent Aug. 14 at 6:29 AM
$ATTO Recent Insider / Institutional Purchases Goldman Sachs / Colin Walsh 585,000 shares @ $17.58 avg $10.285M Redmile Group / Jeremy Green 600,000 shares @ $17.00 $10.20M Frazier Life Sciences XI 588,235 shares @ $17.00 $10.00M venBio Global Strategic Fund IV 382,352 shares @ $17.00 $6.50M Sanofi 300,000 shares @ $17.00 $5.10M TOTAL: ~2.46M shares purchased ~$42.1M in disclosed purchases
0 · Reply
IPOtweet
IPOtweet Aug. 10 at 2:25 PM
IPO Winners & Losers: New Stocks Surge, Biotech Booms, and AI Rallies $BRVE $SPCX $ATTO $FOIL $IPO #IPO https://zpr.io/yd74U46V5uJD
0 · Reply
IPOtweet
IPOtweet Aug. 7 at 10:26 PM
US IPO Weekly Recap: August kicks off with flurry of biotech IPOs $BRVE $LTGO $ATTO $RCBC $BLSM $IPO #IPO https://zpr.io/BtW8qZ4wFgs2
0 · Reply
JFais
JFais Aug. 17 at 8:35 PM
$ATTO (NP) Too early-stage for me, but wanted to highlight yet another of the latest biotech IPO's to be performing well out of the gate $XBI As long as this is the trend for newly public co's, bodes well for the sector (vs all the science projects & bio-blowups we saw prior)
0 · Reply
Invescent
Invescent Aug. 14 at 6:29 AM
$ATTO Recent Insider / Institutional Purchases Goldman Sachs / Colin Walsh 585,000 shares @ $17.58 avg $10.285M Redmile Group / Jeremy Green 600,000 shares @ $17.00 $10.20M Frazier Life Sciences XI 588,235 shares @ $17.00 $10.00M venBio Global Strategic Fund IV 382,352 shares @ $17.00 $6.50M Sanofi 300,000 shares @ $17.00 $5.10M TOTAL: ~2.46M shares purchased ~$42.1M in disclosed purchases
0 · Reply
IPOtweet
IPOtweet Aug. 10 at 2:25 PM
IPO Winners & Losers: New Stocks Surge, Biotech Booms, and AI Rallies $BRVE $SPCX $ATTO $FOIL $IPO #IPO https://zpr.io/yd74U46V5uJD
0 · Reply
IPOtweet
IPOtweet Aug. 7 at 10:26 PM
US IPO Weekly Recap: August kicks off with flurry of biotech IPOs $BRVE $LTGO $ATTO $RCBC $BLSM $IPO #IPO https://zpr.io/BtW8qZ4wFgs2
0 · Reply